Alligator Bioscience AB (publ) (ATORX.ST)

SEK 6.3

(-3.37%)

Long Term Debt Summary of Alligator Bioscience AB (publ)

  • Alligator Bioscience AB (publ)'s latest annual long term debt in 2023 was 7.51 Million SEK , down -53.03% from previous year.
  • Alligator Bioscience AB (publ)'s latest quarterly long term debt in 2024 Q3 was - SEK , down 0.0% from previous quarter.
  • Alligator Bioscience AB (publ) reported annual long term debt of 16 Million SEK in 2022, up 355.8% from previous year.
  • Alligator Bioscience AB (publ) reported annual long term debt of 3.51 Million SEK in 2021, down -39.89% from previous year.
  • Alligator Bioscience AB (publ) reported quarterly long term debt of - SEK for 2024 Q3, down 0.0% from previous quarter.
  • Alligator Bioscience AB (publ) reported quarterly long term debt of 3.23 Million SEK for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Alligator Bioscience AB (publ) (2023 - 2014)

Historical Annual Long Term Debt of Alligator Bioscience AB (publ) (2023 - 2014)

Year Long Term Debt Long Term Debt Growth
2023 7.51 Million SEK -53.03%
2022 16 Million SEK 355.8%
2021 3.51 Million SEK -39.89%
2020 5.84 Million SEK -48.13%
2019 11.26 Million SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%

Peer Long Term Debt Comparison of Alligator Bioscience AB (publ)

Name Long Term Debt Long Term Debt Difference
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.2%
AcouSort AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK -150.533%
Alzinova AB (publ) 800 Thousand SEK -839.5%
Amniotics AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -651.6%
BioArctic AB (publ) 2.15 Million SEK -249.257%
Camurus AB (publ) 13.61 Million SEK 44.788%
Cantargia AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Genovis AB (publ.) 74.8 Million SEK 89.953%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -784.235%
Kancera AB (publ) - SEK -Infinity%
Karolinska Development AB (publ) - SEK -Infinity%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK -326.803%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 76.932%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 88.479%
Simris Alg AB (publ) 90.74 Million SEK 91.717%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Xbrane Biopharma AB (publ) 112.89 Million SEK 93.343%
Xintela AB (publ) - SEK -Infinity%
Ziccum AB (publ) 286 Thousand SEK -2527.972%
Isofol Medical AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 76.474%
CombiGene AB (publ) - SEK -Infinity%
Diamyd Medical AB (publ) 30.67 Million SEK 75.496%
Intervacc AB (publ) 142 Thousand SEK -5192.958%
Sprint Bioscience AB (publ) - SEK -Infinity%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 69.336%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK -74.953%
Spago Nanomedical AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -1672.642%
Egetis Therapeutics AB (publ) 103.4 Million SEK 92.731%
2cureX AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.11%
Cyxone AB (publ) 74 Thousand SEK -10056.757%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -423.398%
Biosergen AB - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -5426.471%
SynAct Pharma AB 58 Thousand SEK -12858.621%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
BioInvent International AB (publ) 14.53 Million SEK 48.29%
Stayble Therapeutics AB (publ) 850 Thousand SEK -784.235%
Oncopeptides AB (publ) 106.48 Million SEK 92.942%
Pila Pharma AB (publ) - SEK -Infinity%
Ascelia Pharma AB (publ) 176 Thousand SEK -4170.455%
Diagonal Bio AB (publ) - SEK -Infinity%